Driven by its proprietary Enhanced Delivery Oligonucleotide (EDO) platform, PepGen is creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic diseases, with an initial focus on neuromuscular diseases.

Biotechnology

PepGen

PepGen's headquarters in Cambridge, MA, United States

James McArthur

Christine W.

Laurie Keating

Emiko Bryant

Hayley Parker

Niels Svenstrup

Debra Sawyer

Noel Donnelly

Jaya Goyal

Michelle Mellion

Leadership Team

Scientific Advisory

Regulatory and Quality

PepGen

Org chart

Teams

Leadership Team

Scientific Advisory

Regulatory and Quality

Offices

Similar companies